Tchaikapharma High Quality Medicines AD

BUL:THQM 주식 보고서

시가총액: лв1.6b

Tchaikapharma High Quality Medicines AD 과거 수익 실적

과거 기준 확인 1/6

Tchaikapharma High Quality Medicines AD's earnings have been declining at an average annual rate of -16.2%, while the Pharmaceuticals industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 5.9% per year. Tchaikapharma High Quality Medicines AD's return on equity is 1.8%, and it has net margins of 3.9%.

주요 정보

-16.2%

수익 성장률

-17.7%

EPS 성장률

Pharmaceuticals 산업 성장12.4%
매출 성장률5.9%
자기자본 수익률1.8%
순이익3.9%
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Is Tchaikapharma High Quality Medicines AD (BUL:7TH) A Risky Investment?

Jan 20
Is Tchaikapharma High Quality Medicines AD (BUL:7TH) A Risky Investment?

Can You Imagine How Elated Tchaikapharma High Quality Medicines AD's (BUL:7TH) Shareholders Feel About Its 317% Share Price Gain?

Dec 10
Can You Imagine How Elated Tchaikapharma High Quality Medicines AD's (BUL:7TH) Shareholders Feel About Its 317% Share Price Gain?

수익 및 비용 분석

Tchaikapharma High Quality Medicines AD 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

BUL:THQM 수익, 비용 및 수입 (BGN Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 24492380
31 Mar 24483330
31 Dec 23493280
30 Sep 23504300
30 Jun 23464240
31 Mar 23443240
31 Dec 22433240
30 Sep 2240160
30 Jun 2243160
31 Mar 2242060
31 Dec 2142160
30 Sep 2142060
30 Jun 2141050
31 Mar 2143150
31 Dec 2040050
30 Sep 2039250
30 Jun 2038140
31 Mar 2036140
31 Dec 1935340
30 Sep 1939940
30 Jun 19381140
31 Mar 19381140
31 Dec 18381140
30 Sep 18351040
30 Jun 18351040
31 Mar 1835940
31 Dec 1733940
30 Sep 1734740
30 Jun 1733840
31 Mar 1732930
31 Dec 1633930
30 Sep 1632930
30 Jun 1632830
31 Mar 1631830
31 Dec 1530840
30 Sep 1533740
30 Jun 1532750
31 Mar 1530750
31 Dec 1429750
31 Dec 1326630

양질의 수익: THQM has high quality earnings.

이익 마진 증가: THQM's current net profit margins (3.9%) are lower than last year (9.7%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: THQM's earnings have declined by 16.2% per year over the past 5 years.

성장 가속화: THQM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

수익 대 산업: THQM had negative earnings growth (-57.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (4.5%).


자기자본 수익률

높은 ROE: THQM's Return on Equity (1.8%) is considered low.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기